Hikal informs about unaudited financial results

24 Oct 2018 Evaluate

Hikal has informed that the meeting of the Board of Directors of the Company is scheduled on 01/11/2018, to consider and approve unaudited financial results for quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

227.70 0.05 (0.02%)
31-Dec-2025 13:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1270.60
Cipla 1505.95
Zydus Lifesciences 913.60
Lupin 2113.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×